Lexaria Bioscience Corp. Common Stock (NASDAQ: LEXX) last traded at $10.92, down 3.15% on the session. The quote above updates while this page is open; the figures below are drawn from Lexaria Bioscience Corp. Common Stock’s own filings and are restated only when a new one is published.
Lexaria Bioscience Corp. Common Stock trades on NASDAQ under the ticker LEXX. Its market capitalisation is $270.55 million.
Valuation measures for Lexaria Bioscience Corp. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $270.55M |
|---|---|
| Enterprise value | $267.49M |
| Price / sales | 1394.61 |
| Price / book | 57.10 |
| Beta | 4.93 |
Trailing-twelve-month figures tagged in Lexaria Bioscience Corp. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $194.0K |
|---|---|
| Net income (TTM) | -$7.73M |
| EPS (TTM) | -$0.350 |
| Gross margin | 100.00% |
| Operating margin | -3973.16% |
| Return on equity | -163.18% |
| Cash | $3.50M |
Range and volume for LEXX over the past 52 weeks.
| 52-week high | $23.25 |
|---|---|
| 52-week low | $4.21 |
| Volume | 8.6K |
| Average volume | 73.6K |
| Previous close | $11.27 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.